2m 2m 2m 2m 2m 2m 2m
BIONXS GENE LAB (BGLC)
NASDAQ
$1.39+$0.07 (+5.30%)
Price as of Aug 03, 2026 12:41 PM EDT- $3.2MMarket Cap
- -79.60%1-Year Change
- Specialty ChemicalsIndustry
BIONXS GENE LAB (BGLC)
$1.39+$0.07 (+5.30%)
BGLC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.32 | ||
Change | $0.00 (0.00%) | ||
Open | $1.32 | ||
High | $1.37 | ||
Low | $1.27 | ||
Previous Close | $1.32 | ||
Volume | 10,006 | ||
30-Day Average Volume | 9,798 | ||
1-Week Change | -12.58% | ||
1-Month Change | -32.31% | ||
1-Year Change | -79.60% | ||
3-Year Change | -94.08% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.4M | ||
Total Assets | $9.0M | ||
Market Cap | $3.2M | ||
Enterprise Value | $1.9M | ||
Period: QTR TTM FY | |||
Revenue | $22,842.00 | ||
Net Income | -$543,575.00 | ||
Free Cash Flow | -$147,996.00 | ||
EBIT | -$543,575.00 | ||
EBITDA | -$515,282.00 | ||
Net Working Capital | $4.4M | ||
EPS | -$0.23 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 81 | ||
P/B | 0 | ||
P/E | -6 | ||
PEG | N/A | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/07/2025 | ||
Earnings & Revenue